Short-course radiation for nasopharyngeal cancer
Part of Cancer, Ear, nose & throat, Mouth & dental clinical trials.
This trial tests a shorter course of radiation therapy for people with nasopharyngeal cancer, a type of head and neck cancer. The goal is to see if a hypofractionated (fewer, larger doses) approach is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with a specific type of nasopharyngeal cancer called non-keratinizing carcinoma.
- You have at least one tumor that can be measured on a scan.
- Your overall health is good enough that you can care for yourself (performance status 0-2).
- Your blood counts, kidney and liver function are within certain safe limits.
- You are not pregnant or breastfeeding, and you do not have another active cancer.
- You have not taken part in another research study in the past 4 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a lower dose of radiation is just as effective as the standard dose for people with early-stage nasopharyngeal cancer, and aims to reduce side effects while keeping the cancer under control.
This trial tests a more precise form of radiation therapy (adaptive radiotherapy) for nasopharyngeal cancer. It is designed for patients who have not yet had any treatment and whose cancer is limited to the head and neck area.
This trial tests whether a smaller radiation treatment area is as effective as the usual larger one for people whose metastatic nasopharyngeal cancer has responded well to first-line chemotherapy plus immunotherapy. It aims to reduce side effects while keeping the cancer under control.
This trial tests whether a personalized radiation plan for the neck can prevent cancer from spreading in people with nasopharyngeal carcinoma. It's for those whose cancer hasn't spread beyond the head and neck area.
This trial compares a lower dose of radiation to the standard dose for people with advanced nasopharyngeal cancer that shrank after chemotherapy and immunotherapy. The goal is to see if a lower dose works just as well with fewer side effects.
This study compares two types of radiation therapy—proton therapy and standard photon therapy—for patients with newly diagnosed nasopharyngeal cancer that has not spread to distant organs. Proton therapy may reduce radiation exposure to healthy tissue around the tumor.
Hear when a new Nasopharyngeal Carcinoma (NPC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.